Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBMNeoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumorActive, not recruitingPhase 22026-08-06NCT03862430

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
NuvOx LLC4

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Atlantic Health SystemSummitUnited States2
Center for NeurosciencesTucsonUnited States19
Duke University Medical CenterDurhamUnited States505
Inova Schar Cancer InstituteFairfaxUnited States116
Ochsner Clinic FoundationNew OrleansUnited States69
Providence St. John's Cancer InstituteSanta MonicaUnited States1
Saint Luke's Cancer InstituteKansas CityUnited States18
St. Francis Medical Center, OSF HealthcarePeoriaUnited States1
UC Irvine Health- Chao Family Comprehensive Cancer CenterOrangeUnited States1
University Hospitals Seidman Cancer CenterClevelandUnited States10
University of ArizonaTucsonUnited States18
Yale Cancer CenterNew HavenUnited States31